Business · 01/06/1998
FDA Approves New Animal Drug for Flea Control in Cats
The US Food and Drug Administration (FDA) is updating its regulations to reflect the approval of a new animal drug application (NADA) submitted by Novartis Animal Health US, Inc. for the use of lufenuron suspension in cats to control flea populations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →